Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 136

1.

Anti-PD-1-Related Cryoglobulinemia during treatment with nivolumab in NSCLC patient.

Pellegrino B, Musolino A, Tiseo M.

Ann Oncol. 2017 Apr 5. doi: 10.1093/annonc/mdx126. [Epub ahead of print] No abstract available.

PMID:
28383638
2.

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition.

Facchinetti F, Rossi G, Bria E, Soria JC, Besse B, Minari R, Friboulet L, Tiseo M.

Cancer Treat Rev. 2017 Mar 12;55:83-95. doi: 10.1016/j.ctrv.2017.02.010. [Epub ahead of print] Review.

PMID:
28342334
3.

Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.

Facchinetti F, Proto C, Minari R, Garassino M, Tiseo M.

Handb Exp Pharmacol. 2017 Mar 23. doi: 10.1007/164_2017_16. [Epub ahead of print]

PMID:
28332047
4.

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).

Di Maio M, Bruzzi P, Perrone F, Torri V, Montemurro F, Tiseo M, Vasile E.

ESMO Open. 2016 Dec 12;1(6):e000109. doi: 10.1136/esmoopen-2016-000109. eCollection 2016. Review.

5.

Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).

Tiseo M, Damato A, Longo L, Barbieri F, Bertolini F, Stefani A, Migaldi M, Gnetti L, Camisa R, Bordi P, Buti S, Rossi G.

Lung Cancer. 2017 Feb;104:24-30. doi: 10.1016/j.lungcan.2016.12.005. Epub 2016 Dec 14.

PMID:
28212996
6.
7.

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial.

Tiseo M, Boni L, Ambrosio F, Camerini A, Baldini E, Cinieri S, Brighenti M, Zanelli F, Defraia E, Chiari R, Dazzi C, Tibaldi C, Turolla GM, D'Alessandro V, Zilembo N, Trolese AR, Grossi F, Riccardi F, Ardizzoni A.

J Clin Oncol. 2017 Apr 20;35(12):1281-1287. doi: 10.1200/JCO.2016.69.4844. Epub 2017 Jan 30.

PMID:
28135143
8.

Extra-pleuric coaxial system for CT-guided percutaneous fine-needle aspiration biopsy (FNAB) of small (≤20 mm) lung nodules: a novel technique using multiplanar reconstruction (MPR) images.

Capasso R, Nizzoli R, Tiseo M, Pedrazzi G, Brunese L, Rotondo A, De Filippo M.

Med Oncol. 2017 Feb;34(2):17. doi: 10.1007/s12032-016-0871-4. Epub 2016 Dec 29.

PMID:
28035579
9.

'Turban-like' skull metastasis from pulmonary adenocarcinoma.

Mengoli MC, Rossi G, Tiseo M, Barbieri F, Pifferi M, Bertolini F, Lococo F.

Thorax. 2016 Dec 2. pii: thoraxjnl-2016-209409. doi: 10.1136/thoraxjnl-2016-209409. [Epub ahead of print] No abstract available.

PMID:
27913767
10.

Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder.

Bersanelli M, Bini P, Rabaiotti E, Facchinetti F, De Filippo M, Bortesi B, Buti S, Tiseo M.

Tumori. 2017 Jan 21;103(1):66-71. doi: 10.5301/tj.5000423. Epub 2015 Sep 19.

PMID:
26391764
11.

Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC.

Facchinetti F, Marabelle A, Rossi G, Soria JC, Besse B, Tiseo M.

J Thorac Oncol. 2016 Nov;11(11):1819-1836. doi: 10.1016/j.jtho.2016.05.027. Epub 2016 Jun 8. Review.

PMID:
27288978
12.

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.

Ardizzoni A, Tiseo M, Boni L, Di Maio M, Buffoni L, Belvedere O, Grossi F, D'Alessandro V, de Marinis F, Barbera S, Caroti C, Favaretto A, Cortinovis D, Morrica B, Tixi L, Ceschia T, Parisi S, Ricardi U, Grimaldi A, Loreggian L, Navarria P, Huber RM, Belani C, Bruswig PF, Scagliotti GV, Scolaro T.

Lung Cancer. 2016 Oct;100:30-7. doi: 10.1016/j.lungcan.2016.07.026. Epub 2016 Jul 27.

PMID:
27597278
13.

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer.

Cappuzzo F, Morabito A, Normanno N, Bidoli P, Del Conte A, Giannetta L, Montanino A, Mazzoni F, Buosi R, Burgio MA, Cerea G, Chiari R, Cortinovis D, Finocchiaro G, Foltran L, Migliorino MR, Tiseo M, Ferrari S, De Marinis F.

Lung Cancer. 2016 Sep;99:31-7. doi: 10.1016/j.lungcan.2016.06.008. Epub 2016 Jun 14.

PMID:
27565910
14.
15.

MET DNA Alterations in NSCLC-Letter.

Mengoli MC, Bertolini F, Tiseo M, Barbieri F, Fiorentino M, Ardizzoni A, Rossi G.

Clin Cancer Res. 2016 Jul 15;22(14):3697-8. doi: 10.1158/1078-0432.CCR-16-0351. No abstract available.

PMID:
27422202
16.

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors.

Facchinetti F, Tiseo M, Di Maio M, Graziano P, Bria E, Rossi G, Novello S.

Transl Lung Cancer Res. 2016 Jun;5(3):301-21. doi: 10.21037/tlcr.2016.06.10. Review.

17.

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.

Novello S, Pinto C, Torri V, Porcu L, Di Maio M, Tiseo M, Ceresoli G, Magnani C, Silvestri S, Veltri A, Papotti M, Rossi G, Ricardi U, Trodella L, Rea F, Facciolo F, Granieri A, Zagonel V, Scagliotti G.

Crit Rev Oncol Hematol. 2016 Aug;104:9-20. doi: 10.1016/j.critrevonc.2016.05.004. Epub 2016 May 13.

PMID:
27286698
18.

L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC.

Bersanelli M, Minari R, Bordi P, Gnetti L, Bozzetti C, Squadrilli A, Lagrasta CA, Bottarelli L, Osipova G, Capelletto E, Mor M, Tiseo M.

J Thorac Oncol. 2016 Oct;11(10):e121-3. doi: 10.1016/j.jtho.2016.05.019. Epub 2016 May 31. No abstract available.

PMID:
27257132
19.

2PD Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC.

Bordi P, Del Re M, Danesi R, Tiseo M.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S57. doi: 10.1016/S1556-0864(16)30117-4. Epub 2016 Apr 15. No abstract available.

20.

209P: SMO mutation is a strong negative prognostic factor in malignant pleural mesothelioma.

Signorelli D, Proto C, Ganzinelli M, Lo Russo G, Botta L, Trama A, Pasello G, Tiseo M, Pelosi G, Garassino M.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S147. doi: 10.1016/S1556-0864(16)30316-1. Epub 2016 Apr 15. No abstract available.

Supplemental Content

Support Center